Stanodex 50 INJ Sciroxx

£51.00

Stanodex 50 INJ is a stanozolol-based injectable research compound developed by Sciroxx laboratories for advanced in-vitro anabolic steroid receptor studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Stanodex 50 INJ Sciroxx
Stanodex 50 INJ Sciroxx
£51.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Stanodex 50 INJ Research Compound Overview

Stanodex 50 INJ is a synthetic anabolic steroid research compound containing stanozolol as the active pharmaceutical ingredient, manufactured by Sciroxx laboratories. This injectable formulation represents a modified dihydrotestosterone derivative engineered for comprehensive androgen receptor research applications. The compound exhibits unique structural modifications that differentiate it from testosterone-based analogues, making it particularly valuable for investigating selective androgenic pathways in laboratory settings. Researchers at Stroid UK Shop utilise this compound to examine anabolic-androgenic ratios and receptor binding characteristics in controlled experimental environments.

Laboratory Research Applications

Scientific investigations with Stanodex 50 INJ focus primarily on evaluating its distinctive pharmacological profile compared to other anabolic compounds. Researchers examine the compound’s interaction with androgen receptors to better understand tissue-selective effects in muscle and bone cell cultures. The injectable delivery system enables precise experimental protocols when studying bioavailability and pharmacokinetic parameters. Studies frequently analyse the compound’s metabolic pathways and enzymatic interactions within hepatic cell models. Steroid injection research protocols often incorporate this formulation alongside other compounds from the SARMs collection and peptide research range to establish comprehensive comparative analyses.

Stanodex 50 INJ Specifications

Technical specifications for Stanodex 50 INJ research compound
Parameter Value
Active Ingredient Stanozolol
Concentration 50mg/mL
Formulation Injectable Solution
Manufacturer Sciroxx
CAS Number 10418-03-8
Molecular Formula C₂₁H₃₂N₂O
Molecular Weight 328.49 g/mol
Storage Temperature Room temperature, dry environment

Research Compliance Statement

Stanodex 50 INJ is manufactured exclusively for in-vitro research applications and laboratory analytical studies. This compound is not approved for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must ensure proper laboratory protocols, safety equipment, and regulatory compliance when handling this research chemical. All experimental procedures should follow institutional guidelines for chemical research and waste disposal. This product is intended solely for qualified research institutions and licensed laboratories conducting legitimate scientific investigations into anabolic steroid mechanisms and receptor interactions.

Related